Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290648 · ClinicalTrials.gov registry record · NA
Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings
A NA study of Mental Illness, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT06290648: Active NA study of Mental Illness, sponsored by University of North Carolina, Chapel Hill.
NCT06290648 is a NA study of Mental Illness that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 72 participants, below the 188-participant average among 11 other Mental Illness trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06290648, a NA study of Mental Illness, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to conduct a preliminary test of the effectiveness of Forging New Paths for people with mental illness with criminal legal system contact. The main question\[s\] it aims to answer are: 1. To examine the effectiveness of Forging New Paths at improving the primary study outcomes (aggression and community tenure). 2. To test the ability of Forging New Paths to engage the study treatment targets (impulsivity and criminal attitudes) Participants will complete a screening interviews to see if they are eligible. Participants who are eligible will be randomly assigned to participate in one of two study conditions: Forging New Paths and usual care or usual care alone. All participants who are assigned to a study condition will participate in up to three additional research interviews. Researchers will also collect information about study outcomes using administrative records.
Primary Outcome
Aggression Questionnaire (Bryant \& Smith, 2001) - Short Form is a 12-item measure with four subscales: physical aggression, verbal aggression, anger, and hostility. Items are scored on a 6-point Likert scale. Scores range from 12 to 72. The higher the score the more aggression present.
Conditions Studied
Interventions
- BEHAVIORAL Forging New Paths
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2026-01-30 |
| Phase | NA |
What the registry record for NCT06290648 still lists
NCT06290648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 188-participant average among 11 other Mental Illness trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Mental Illness appearing as the primary indexed condition, and to 1 intervention - of which Forging New Paths is the first listed.
NCT06290648 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06290648 about?
NCT06290648 is a clinical study titled "Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings". The goal of this clinical trial is to conduct a preliminary test of the effectiveness of Forging New Paths for people with mental illness with criminal legal system contact. The main question\[s\] it aims to answer are: 1. To examine the effectiveness of Forging New Paths at improving the primary s...
What is the current status of trial NCT06290648?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 72 participants. The study started on 2024-04-01. Estimated completion is 2026-01-30.
What conditions does trial NCT06290648 study?
This clinical trial studies the following conditions: Mental Illness.
What interventions are being tested in trial NCT06290648?
The interventions under investigation include: Forging New Paths (BEHAVIORAL).
Who is sponsoring clinical trial NCT06290648?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290648 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06290648's enrollment target sits among peer trials
72 8th of 11 higher than 4 of 11 other Mental Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of IIMR Versus CDSMP
RECRUITING · NA
-
Successful Transitions and Reintegration Tools for Veterans (START-VETS)
RECRUITING · NA
-
Harm Reduction Services
RECRUITING · NA
-
"Recovery 4 US" - A Photovoice-based Social Media Program
COMPLETED · NA
-
Wellness Self-Management
COMPLETED · NA
-
Bridging Community Gaps Photovoice
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI